Lenzing India and Ruby Mills Ltd have come together to present H+ Technology™ – for an antiviral, antibacterial and antifungal fabric. This breakthrough comes at a crucial time when India is facing an increasing number of cases. H+ technology’s efficacy has been tested and the findings successfully indicate that viruses and microbes won’t survive on the surface of the fabric that’s been treated with it – thus helping to arrest the spread of the virus.
Search Results: Covid (1433)
Lenzing India and Ruby Mills Ltd have come together to present H+ Technology™ – for an antiviral, antibacterial and antifungal fabric. This breakthrough comes at a crucial time when India is facing an increasing number of cases. H+ technology’s efficacy has been tested and the findings successfully indicate that viruses and microbes won’t survive on the surface of the fabric that’s been treated with it – thus helping to arrest the spread of the virus.
Lenzing India and Ruby Mills Ltd have come together to present H+ Technology™ – for an antiviral, antibacterial and antifungal fabric. This breakthrough comes at a crucial time when India is facing an increasing number of cases. H+ technology’s efficacy has been tested and the findings successfully indicate that viruses and microbes won’t survive on the surface of the fabric that’s been treated with it – thus helping to arrest the spread of the virus.
Between May 20 and June 8, 2020, ITMF has conducted its 4th ITMF Corona-Survey among ITMF members and affiliated companies and associations about the impact the Corona-pandemic had on the global textile value chain. In total around 600 companies from around the world participated.
HeiQ Viroblock NPJ03 is among the first textile technologies in the world to be proven effective against SARS-CoV-2 in the laboratory.
HeiQ Viroblock NPJ03 is among the first textile technologies in the world to be proven effective against SARS-CoV-2 in the laboratory.
HeiQ Viroblock NPJ03 is among the first textile technologies in the world to be proven effective against SARS-CoV-2 in the laboratory.